Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 196

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia

Open access
Avendaño-Solá, Cristina, Ramos-Martínez, Antonio, Muñez-Rubio, Elena, Ruiz-Antorán, Belen, Malo de Molina, Rosa, Torres, Ferran, Fernández-Cruz, Ana, Calderón-Parra, Jorge, Payares-Herrera, Concepcion, Díaz de Santiago, Alberto, Romera-Martínez, Irene, Pintos, Ilduara, Lora-Tamayo, Jaime, Mancheño-Losa, Mikel, Paciello, Maria L., Martínez-González, A.L., Vidán-Estévez, Julia, Nuñez-Orantos, Maria J., Saez-Serrano, Maria Isabel, Porras-Leal, Maria L., Jarilla-Fernández, Maria C., Villares, Paula, de Oteyza, Jaime Pérez, Ramos-Garrido, Ascension, Blanco, Lydia, Madrigal-Sánchez, Maria E., Rubio-Batllés, Martin, Velasco-Iglesias, Ana, Paño-Pardo, José R., Moreno-Chulilla, J.A., Muñiz-Díaz, Eduardo, Casas-Flecha, Inmaculada, Pérez-Olmeda, Mayte, García-Pérez, Javier, Alcamí, Jose, Bueno, Jose L., Duarte, Rafael F. · 2021 · Journal of Clinical Investigation

Abstract

BACKGROUNDPassive immunotherapy with convalescent plasma (CP) is a potential treatment for COVID-19. Evidence from controlled clinical trials is inconclusive.METHODSWe conducted a randomized, open-label, controlled clinical trial at 27 hospitals in Spain. Patients had to be admitted for COVID-19 pneumonia within 7 days from symptom onset and not on mechanical ventilation or high-flow oxygen devices. Patients were randomized 1:1 to treatment with CP in addition to standard of care (SOC) or to the control arm receiving only SOC. The primary endpoint was the proportion of patients in categories 5 (noninvasive ventilation or high-flow oxygen), 6 (invasive mechanical ventilation or extracorporeal membrane oxygenation [ECMO]), or 7 (death) at 14 days. Primary analysis was performed in the intention-to-treat population.RESULTSBetween April 4, 2020, and February 5, 2021, 350 patients were randomly assigned to either CP (n = 179) or SOC (n = 171). At 14 days, proportion of patients in categories 5, 6, or 7 was 11.7% in the CP group versus 16.4% in the control group (P = 0.205). The difference was greater at 28 days, with 8.4% of patients in categories 5-7 in the CP group versus 17.0% in the control group (P = 0.021). The difference in overall survival did not reach statistical significance (HR 0.46, 95% CI 0.19-1.14, log-rank P = 0.087).CONCLUSIONCP showed a significant benefit in preventing progression to noninvasive ventilation or high-flow oxygen, invasive mechanical ventilation or ECMO, or death at 28 days. The effect on the predefined primary endpoint at 14 days and the effect on overall survival were not statistically significant.TRIAL REGISTRATIONClinicaltrials.gov, NCT04345523.FUNDINGGovernment of Spain, Instituto de Salud Carlos III.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci152740

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 196

Metadata

Authors
Avendaño-Solá, C., Ramos-Martínez, A., Muñez-Rubio, E., Ruiz-Antorán, B., Malo de Molina, R., Torres, F., Fernández-Cruz, A., Calderón-Parra, J., Payares-Herrera, C., Díaz de Santiago, A., Romera-Martínez, I., Pintos, I., Lora-Tamayo, J., Mancheño-Losa, M., Paciello, M. L., Martínez-González, A. L., Vidán-Estévez, J., Nuñez-Orantos, M. J., Saez-Serrano, M. I., Porras-Leal, M. L., Jarilla-Fernández, M. C., Villares, P., de Oteyza, J. P., Ramos-Garrido, A., Blanco, L., Madrigal-Sánchez, M. E., Rubio-Batllés, M., Velasco-Iglesias, A., Paño-Pardo, J. R., Moreno-Chulilla, J. A., Muñiz-Díaz, E., Casas-Flecha, I., Pérez-Olmeda, M., García-Pérez, J., Alcamí, J., Bueno, J. L., & Duarte, R. F.
Venue
Journal of Clinical Investigation
Published
2021-10-15
Volume
131
Issue
20
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W3198314694
Cited by
196
References
4
FWCI
13.10
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia. https://app.cochat.ai/papers/10.1172/jci152740
The paper
Avendaño-Solá, C., Ramos-Martínez, A., Muñez-Rubio, E., Ruiz-Antorán, B., Malo de Molina, R., Torres, F., Fernández-Cruz, A., Calderón-Parra, J., Payares-Herrera, C., Díaz de Santiago, A., Romera-Martínez, I., Pintos, I., Lora-Tamayo, J., Mancheño-Losa, M., Paciello, M. L., Martínez-González, A. L., Vidán-Estévez, J., Nuñez-Orantos, M. J., Saez-Serrano, M. I., . . . Duarte, R. F. (2021). A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia. Journal of Clinical Investigation. https://doi.org/10.1172/jci152740

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.